MobiHealth News October 23, 2023
The technology company will integrate Sibel’s Discovery platform into its offerings, allowing researchers to gather insights from Sibel’s wearable sensor technology.
Sibel Health, a spin-out of Northwestern University, announced the release of its physiological monitoring platform for clinical trial use dubbed Discovery alongside a partnership with AI-powered clinical trial solutions company Medidata.
The Illinois-based healthcare technology platform Discovery utilizes its FDA-cleared wearable sensors to monitor participants’ digital endpoints and vital signs during a clinical trial, including heart rate, blood pressure, SpO2, respiratory rate, and temperature.
Medidata, which offers AI-enabled digital solutions to support life sciences companies during clinical trials, will integrate Discovery into its cloud-based platform, allowing pharma companies and research organizations to access participants’ Sibel data.
...Today's Sponsors
Today's Sponsor